1. Home
  2. CNXN vs CSTL Comparison

CNXN vs CSTL Comparison

Compare CNXN & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CNXN

PC Connection Inc.

HOLD

Current Price

$58.16

Market Cap

1.5B

ML Signal

HOLD

Logo Castle Biosciences Inc.

CSTL

Castle Biosciences Inc.

HOLD

Current Price

$39.00

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNXN
CSTL
Founded
1982
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.2B
IPO Year
1998
2019

Fundamental Metrics

Financial Performance
Metric
CNXN
CSTL
Price
$58.16
$39.00
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$46.67
AVG Volume (30 Days)
63.5K
371.3K
Earning Date
02-04-2026
02-26-2026
Dividend Yield
1.04%
N/A
EPS Growth
N/A
N/A
EPS
3.24
N/A
Revenue
$2,878,704,000.00
$343,530,000.00
Revenue This Year
$5.74
$2.55
Revenue Next Year
$4.56
N/A
P/E Ratio
$17.87
N/A
Revenue Growth
3.19
10.15
52 Week Low
$54.97
$14.59
52 Week High
$74.84
$44.28

Technical Indicators

Market Signals
Indicator
CNXN
CSTL
Relative Strength Index (RSI) 48.53 46.13
Support Level $56.20 $39.74
Resistance Level $58.44 $44.28
Average True Range (ATR) 1.32 1.76
MACD -0.02 -0.06
Stochastic Oscillator 61.78 12.49

Price Performance

Historical Comparison
CNXN
CSTL

About CNXN PC Connection Inc.

PC Connection Inc is a provider of information technology solutions. It provides products such as computer systems, software and peripheral equipment, networking communications, and other products and accessories that company purchase from manufacturers and distributors. The company also offers services involving design, configuration, and implementation of IT solutions. It conducts business operations through three business segments namely Connection Business Solutions, Connection Enterprise Solutions, and Connection Public Sector Solutions. The company generates maximum revenue Connection Enterprise Solutions segment.

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.

Share on Social Networks: